93 related articles for article (PubMed ID: 3698017)
1. Phenotypic instability of mouse melanomas after propagation in vivo and in vitro.
Berkelhammer J; Luethans TN; Hook RR; Oxenhandler RW
Cancer Res; 1986 Jun; 46(6):2923-8. PubMed ID: 3698017
[TBL] [Abstract][Full Text] [Related]
2. Development of a new melanoma model in C57BL/6 mice.
Berkelhammer J; Oxenhandler RW; Hook RR; Hennessy JM
Cancer Res; 1982 Aug; 42(8):3157-63. PubMed ID: 7093959
[TBL] [Abstract][Full Text] [Related]
3. A new Mr 55,000 surface protein implicated in melanoma progression: association with a metastatic phenotype.
Boukerche H; Baril P; Tabone E; Bérard F; Sanhadji K; Balme B; Wolf F; Perrot H; Thomas L
Cancer Res; 2000 Oct; 60(20):5848-56. PubMed ID: 11059782
[TBL] [Abstract][Full Text] [Related]
4. Enforced c-KIT expression renders highly metastatic human melanoma cells susceptible to stem cell factor-induced apoptosis and inhibits their tumorigenic and metastatic potential.
Huang S; Luca M; Gutman M; McConkey DJ; Langley KE; Lyman SD; Bar-Eli M
Oncogene; 1996 Dec; 13(11):2339-47. PubMed ID: 8957075
[TBL] [Abstract][Full Text] [Related]
5. Biological and experimental consequences of the zonal composition of solid tumors.
Fidler IJ; Hart IR
Cancer Res; 1981 Aug; 41(8):3266-7. PubMed ID: 7248979
[TBL] [Abstract][Full Text] [Related]
6. Alterations of cell surface carbohydrates and inhibition of metastatic property of murine melanomas by alpha 1,3 galactosyltransferase gene transfection.
Gorelik E; Duty L; Anaraki F; Galili U
Cancer Res; 1995 Sep; 55(18):4168-73. PubMed ID: 7545089
[TBL] [Abstract][Full Text] [Related]
7. Generation of phenotypic diversity in the B16 mouse melanoma relative to spontaneous metastasis.
Stackpole CW
Cancer Res; 1983 Jul; 43(7):3057-65. PubMed ID: 6850615
[TBL] [Abstract][Full Text] [Related]
8. [Studies of the origin of malignant rhabdoid tumor(MRT)--experimental researches on the MRT evolving in nude mice inoculated with violently variable HeLa cells].
Zhang DL; Huang GS; Li LJ; He XY; Xia GT; Gao BX; Bai XH; Liu SG
Yi Chuan Xue Bao; 2000; 27(12):1057-71. PubMed ID: 11209698
[TBL] [Abstract][Full Text] [Related]
9. Multiple features of advanced melanoma recapitulated in tumorigenic variants of early stage (radial growth phase) human melanoma cell lines: evidence for a dominant phenotype.
Bani MR; Rak J; Adachi D; Wiltshire R; Trent JM; Kerbel RS; Ben-David Y
Cancer Res; 1996 Jul; 56(13):3075-86. PubMed ID: 8674065
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of premalignant and malignant lesions during the induction of mouse melanomas.
Berkelhammer J; Oxenhandler RW
Cancer Res; 1987 Mar; 47(5):1251-4. PubMed ID: 3102042
[TBL] [Abstract][Full Text] [Related]
11. Role of interleukin (IL)-2 and IL-15 in the tumour progression of a melanoma cell line MELP, derived from an IL-2 progressor patient.
Doucet C; Meazza R; Pottin-Clemenceau C; Scudeletti M; Brouty-Boye D; Ferrini S; Alileche A; Taoufik Y; Jasmin C; Azzarone B; Indiveri F
Melanoma Res; 1997 Aug; 7 Suppl 2():S7-17. PubMed ID: 9578412
[TBL] [Abstract][Full Text] [Related]
12. Loss of the tumorigenic phenotype with in vitro, but not in vivo, passaging of a novel series of human bronchial epithelial cell lines: possible role of an alpha 5/beta 1-integrin-fibronectin interaction.
Schiller JH; Bittner G
Cancer Res; 1995 Dec; 55(24):6215-21. PubMed ID: 8521416
[TBL] [Abstract][Full Text] [Related]
13. Influence of retinoids on growth and melanin content of Harding-Passey-melanoma cells in vitro and B16 transplantable melanoma in vivo.
Drewa G; Schachtschabel DO
Arch Geschwulstforsch; 1985; 55(2):93-8. PubMed ID: 4004512
[TBL] [Abstract][Full Text] [Related]
14. Tumorigenicity of human malignant melanocytes in nude mice in relation to their differentiation in vitro.
Aubert C; Rougé F; Galindo JR
J Natl Cancer Inst; 1980 May; 64(5):1029-40. PubMed ID: 6929009
[TBL] [Abstract][Full Text] [Related]
15. Murine melanoma-specific tumor rejection activity elicited by a purified, melanoma-associated antigen.
Hearing VJ; Gersten DM; Montague PM; Vieira WD; Galetto G; Law LW
J Immunol; 1986 Jul; 137(1):379-84. PubMed ID: 3711669
[TBL] [Abstract][Full Text] [Related]
16. Influence of organ microenvironment on pigmentation of a metastatic murine melanoma.
Price JE; Tarin D; Fidler IJ
Cancer Res; 1988 Apr; 48(8):2258-64. PubMed ID: 2832058
[TBL] [Abstract][Full Text] [Related]
17. Phenotypic stability of murine tumor cells in vitro and in vivo.
Varani J; Lovett EJ
J Natl Cancer Inst; 1982 Jun; 68(6):957-62. PubMed ID: 6953274
[TBL] [Abstract][Full Text] [Related]
18. Increased immunogenicity of tumor vaccines complexed with anti-Gal: studies in knockout mice for alpha1,3galactosyltransferase.
LaTemple DC; Abrams JT; Zhang SY; Galili U
Cancer Res; 1999 Jul; 59(14):3417-23. PubMed ID: 10416604
[TBL] [Abstract][Full Text] [Related]
19. Tumor cells engineered to express interleukin-6 exhibit a reduced tumorigenicity depending on the tumor cell model.
Ledda MF; Adris S; Bravo AI; Bover L; Carbone C; Paleolog E; Mordoh J; Chernajovsky Y; Podhajcer OL
Cell Mol Biol (Noisy-le-grand); 1996 Jul; 42(5):769-78. PubMed ID: 8832108
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of a nude mouse tumor model using beta-galactosidase-expressing melanoma cells.
Dooley TP; Stamp-Cole M; Ouding RJ
Lab Anim Sci; 1993 Feb; 43(1):48-57. PubMed ID: 7681492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]